Solution structure of a novel ETB receptor selective agonist ET1-21[Cys(Acm)(1,15), Aib(3,11), Leu(7)] by nuclear magnetic resonance spectroscopy andmolecular modelling
Cm. Hewage et al., Solution structure of a novel ETB receptor selective agonist ET1-21[Cys(Acm)(1,15), Aib(3,11), Leu(7)] by nuclear magnetic resonance spectroscopy andmolecular modelling, J PEPT RES, 53(3), 1999, pp. 223-233
The solution structure of a biologically active modified linear endothelin-
l analogue, ET1-21[Cys(Acm)(1,15), Aib(3,11), Leu(7)]. has been determined
for the first time by two-dimensional nuclear magnetic resonance spectrosco
py in a methanol-d(3)/water solvent mixture. Out of approximately one hundr
ed linear peptide analogues tested by biological assay, this peptide, toget
her with a dozen others, showed significant ETB selective agonist activity.
Here we report the solution structure of an ETB selective agonist of a ful
l-length, synthetic linear endothelin analogue. The calculated structures i
ndicate that the peptide adopts an alpha-helical conformation between resid
ues Ser(5)-His(16), whilst both N- and C-termini show no preferred conforma
tion. These results suggest that the disulphide bridges normally associated
with endothelin and sarafotoxin peptides may not necessarily be important
for either ETB receptor binding activity or the formation of a helical conf
ormation in solution.